406 related articles for article (PubMed ID: 26458725)
1. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
[TBL] [Abstract][Full Text] [Related]
2. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
3. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
[TBL] [Abstract][Full Text] [Related]
4. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
5. The orphan nuclear receptor Nur77 inhibits low shear stress-induced carotid artery remodeling in mice.
Yu Y; Cai Z; Cui M; Nie P; Sun Z; Sun S; Chu S; Wang X; Hu L; Yi J; Shen L; He B
Int J Mol Med; 2015 Dec; 36(6):1547-55. PubMed ID: 26498924
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of Rho-kinase inhibition on artery wall mass and remodeling.
Pearce JD; Li J; Edwards MS; English WP; Geary RL
J Vasc Surg; 2004 Jan; 39(1):223-8. PubMed ID: 14718843
[TBL] [Abstract][Full Text] [Related]
7. Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
Sun XZ; Tian XY; Wang DW; Li J
Eur Rev Med Pharmacol Sci; 2014; 18(7):959-64. PubMed ID: 24763873
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.
Greig FH; Hutchison L; Spickett CM; Kennedy S
Clin Sci (Lond); 2015 May; 128(9):579-92. PubMed ID: 25524654
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.
Raja SG
Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):100-4. PubMed ID: 22670803
[TBL] [Abstract][Full Text] [Related]
10. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
[TBL] [Abstract][Full Text] [Related]
11. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
13. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
14. A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model.
Schumacher D; Liehn EA; Nilcham P; Mayan DC; Rattanasopa C; Anand K; Crespo-Avilan GE; Hernandez-Resendiz S; Singaraja RR; Cook SA; Hausenloy DJ
Sci Rep; 2021 Oct; 11(1):20674. PubMed ID: 34667238
[TBL] [Abstract][Full Text] [Related]
15. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
18. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
19. Disruption of TGF-β signaling in smooth muscle cell prevents flow-induced vascular remodeling.
Gao F; Chambon P; Tellides G; Kong W; Zhang X; Li W
Biochem Biophys Res Commun; 2014 Nov; 454(1):245-50. PubMed ID: 25451249
[TBL] [Abstract][Full Text] [Related]
20. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
